The Institute for Neurodegenerative Disorders

05/19/2026

Imaging studies help researchers better understand how neurological conditions affect the brain.
The Institute for Neurodegenerative Disorders is sharing information about imaging research for adults age 45+.
Conditions of interest include MSA, PSP, and CBS.
If you are interested in participating or learning more about the imaging studies, complete the survey at redcap.link/more-info and our research team will contact you.
To learn more about IND, visit https://indd.org.

05/12/2026

We’re building a list of healthy adults interested in future brain research studies.
Healthy adults ages 18 and older may join a healthy volunteer database and be considered for future brain research studies. Participation is voluntary and is not medical care.
Compensation may be provided.
Interested? Visit www.indd.org.

05/04/2026

The Institute for Neurodegenerative Disorders is conducting research that includes brain imaging to better understand rare neurological conditions.
Adults age 45+ may be eligible for imaging research conducted at our New Haven clinic.
Conditions of interest include MSA, PSP, and CBS.
If you are interested in participating or learning more
about the imaging studies, complete the survey at redcap.link/more-info and our research team will contact you.
To learn more about IND, visit https://www.indd.org.

04/28/2026

Healthy adults age 18 and older are invited to learn more about participating in research studies at the Institute for Neurodegenerative Disorders.
To learn more about research participation opportunities, please visit the link and complete the brief survey.
https://redcap.link/more-info

04/13/2026

We are grateful to NBC 10 and Barbara Morse for highlighting the work underway at the Institute for Neurodegenerative Disorders.
At IND, our team is working to advance understanding of Parkinson’s disease and related disorders through clinical research and advanced brain imaging. This includes research involving both people living with Parkinson’s disease and neurologically healthy adults.
Thank you for helping us share why this work matters.
Watch the story here:

"Parkinson's disease is a brain disorder. It affects as many as a million people in the United States," said Dr. Thomas Tropea.

04/07/2026

A clinical research study is enrolling adults ages 40–85 with early Parkinson’s Disease (PD) who have not yet begun Parkinson’s medications.The purpose of this study is to evaluate the safety and potential effects of an investigational drug. Study participation includes visits for medical exams, brain imaging, and health assessments over approximately one year. To learn more or find out if you may be eligible, contact www.indd.org/bh-info

The hope for a cure is through clinical research. Our Mission To advance the development of diagnostic tools and new treatments for patients with neurodegenerative conditions through clinical research. How We HelpIND stands as a premier clinical and imaging research facility. A focus of our research...

04/01/2026

Healthy adults age 18 and older are invited to learn more about participating in research studies at the Institute for Neurodegenerative Disorders.
Researchers are studying neurodegenerative diseases and how the brain changes over time. Healthy volunteers play an important role in helping scientists better understand these conditions.
To learn more and express interest in participating, please complete the brief survey at the link below.
Survey: https://redcap.link/more-info
Learn more about our research: https://indd.org

03/26/2026

Researchers at the Institute for Neurodegenerative Disorders are seeking healthy adults age 18 and older interested in participating in research studies focused on neurodegenerative disease.
Compensation may be available depending on the study.
If you are interested in learning more about research participation, please complete the brief survey.
Survey:� https://redcap.link/more-info

03/19/2026

03/13/2026

Researchers are conducting a clinical study to evaluate an investigational oral medication in adults with early Parkinson’s disease.
You may be eligible if you:
• Are 40–85 years old
• Have experienced the onset of symptoms associated with Parkinson’s disease within the last 2 years
• Have not started Parkinson’s disease medications. Participation lasts about one year, with study visits every few weeks. Learn more or see if you might qualify www.indd.org/bh-info